Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

An Evaluation of Active Learning Causal Discovery Methods for Reverse-Engineering Local Causal Pathways of Gene Regulation.

Ma S, Kemmeren P, Aliferis CF, Statnikov A.

Sci Rep. 2016 Mar 4;6:22558. doi: 10.1038/srep22558.

2.

Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis.

Attur M, Statnikov A, Samuels J, Li Z, Alekseyenko AV, Greenberg JD, Krasnokutsky S, Rybak L, Lu QA, Todd J, Zhou H, Jordan JM, Kraus VB, Aliferis CF, Abramson SB.

Osteoarthritis Cartilage. 2015 Nov;23(11):1915-24. doi: 10.1016/j.joca.2015.08.006.

3.

Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers.

Attur M, Krasnokutsky S, Statnikov A, Samuels J, Li Z, Friese O, Hellio Le Graverand-Gastineau MP, Rybak L, Kraus VB, Jordan JM, Aliferis CF, Abramson SB.

Arthritis Rheumatol. 2015 Nov;67(11):2905-15. doi: 10.1002/art.39279.

4.

Information content and analysis methods for multi-modal high-throughput biomedical data.

Ray B, Henaff M, Ma S, Efstathiadis E, Peskin ER, Picone M, Poli T, Aliferis CF, Statnikov A.

Sci Rep. 2014 Mar 21;4:4411. doi: 10.1038/srep04411.

5.

A comprehensive evaluation of multicategory classification methods for microbiomic data.

Statnikov A, Henaff M, Narendra V, Konganti K, Li Z, Yang L, Pei Z, Blaser MJ, Aliferis CF, Alekseyenko AV.

Microbiome. 2013 Apr 5;1(1):11. doi: 10.1186/2049-2618-1-11.

6.

Microbiomic signatures of psoriasis: feasibility and methodology comparison.

Statnikov A, Alekseyenko AV, Li Z, Henaff M, Perez-Perez GI, Blaser MJ, Aliferis CF.

Sci Rep. 2013;3:2620. doi: 10.1038/srep02620.

7.

Identifying unproven cancer treatments on the health web: addressing accuracy, generalizability and scalability.

Aphinyanaphongs Y, Fu LD, Aliferis CF.

Stud Health Technol Inform. 2013;192:667-71.

8.

Algorithms for Discovery of Multiple Markov Boundaries.

Statnikov A, Lytkin NI, Lemeire J, Aliferis CF.

J Mach Learn Res. 2013 Feb;14:499-566.

9.

New methods for separating causes from effects in genomics data.

Statnikov A, Henaff M, Lytkin NI, Aliferis CF.

BMC Genomics. 2012;13 Suppl 8:S22. doi: 10.1186/1471-2164-13-S8-S22. Epub 2012 Dec 17.

10.

Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome.

Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O.

PLoS One. 2012;7(6):e39790. doi: 10.1371/journal.pone.0039790. Epub 2012 Jun 27.

11.

Expanding the understanding of biases in development of clinical-grade molecular signatures: a case study in acute respiratory viral infections.

Lytkin NI, McVoy L, Weitkamp JH, Aliferis CF, Statnikov A.

PLoS One. 2011;6(6):e20662. doi: 10.1371/journal.pone.0020662. Epub 2011 Jun 1.

12.

Causal graph-based analysis of genome-wide association data in rheumatoid arthritis.

Alekseyenko AV, Lytkin NI, Ai J, Ding B, Padyukov L, Aliferis CF, Statnikov A.

Biol Direct. 2011 May 18;6:25. doi: 10.1186/1745-6150-6-25.

13.

A comparison of evaluation metrics for biomedical journals, articles, and websites in terms of sensitivity to topic.

Fu LD, Aphinyanaphongs Y, Wang L, Aliferis CF.

J Biomed Inform. 2011 Aug;44(4):587-94. doi: 10.1016/j.jbi.2011.03.006. Epub 2011 Mar 17.

14.

Using gene expression profiles from peripheral blood to identify asymptomatic responses to acute respiratory viral infections.

Statnikov A, Lytkin NI, McVoy L, Weitkamp JH, Aliferis CF.

BMC Res Notes. 2010 Oct 20;3:264. doi: 10.1186/1756-0500-3-264.

15.

A comprehensive assessment of methods for de-novo reverse-engineering of genome-scale regulatory networks.

Narendra V, Lytkin NI, Aliferis CF, Statnikov A.

Genomics. 2011 Jan;97(1):7-18. doi: 10.1016/j.ygeno.2010.10.003. Epub 2010 Oct 14.

16.

Analysis and computational dissection of molecular signature multiplicity.

Statnikov A, Aliferis CF.

PLoS Comput Biol. 2010 May 20;6(5):e1000790. doi: 10.1371/journal.pcbi.1000790.

17.

Improving development of the molecular signature for diagnosis of acute respiratory viral infections.

Statnikov A, McVoy L, Lytkin N, Aliferis CF.

Cell Host Microbe. 2010 Feb 18;7(2):100-1; author reply 102. doi: 10.1016/j.chom.2010.01.003. No abstract available.

18.

The FAST-AIMS Clinical Mass Spectrometry Analysis System.

Fananapazir N, Statnikov A, Aliferis CF.

Adv Bioinformatics. 2009:598241. doi: 10.1155/2009/598241. Epub 2009 Jul 9.

19.

A novel information retrieval model for high-throughput molecular medicine modalities.

Wehbe FH, Brown SH, Massion PP, Gadd CS, Masys DR, Aliferis CF.

Cancer Inform. 2009 Feb 9;8:1-17.

20.

Factors influencing the statistical power of complex data analysis protocols for molecular signature development from microarray data.

Aliferis CF, Statnikov A, Tsamardinos I, Schildcrout JS, Shepherd BE, Harrell FE Jr.

PLoS One. 2009;4(3):e4922. doi: 10.1371/journal.pone.0004922. Epub 2009 Mar 17.

Supplemental Content

Loading ...
Support Center